AtriCure stock falls 1.45 percent as earnings approach

Published on 09/22/2026 at 07:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

AtriCure stock traded at USD 57.26 on September 22, 2026, down 1.45 percent from the prior close. Q2 FY26 revenue reached USD 153.6 million.

ATRC, US04963C1099, Illustration mit AI erstellt.

AtriCure stock (ISIN US04963C1099) traded at USD 57.26 on Nasdaq on September 22, 2026, down 1.45 percent from the previous close of USD 58.10. The move leaves the shares close to the 52-week high of USD 59.88 and well above the 52-week low of USD 25.36.

Quarterly revenue reaches USD 153.6 million

AtriCure reported second-quarter fiscal 2026 revenue of USD 153.6 million and earnings of USD 8.96 million, according to Yahoo Finance on September 22, 2026. The reported profit margin was 5.83 percent for that period.

The earnings figure compares with a second-quarter fiscal 2026 estimate of USD 0.02 per share, while the reported actual figure was USD 0.18 per share, a difference of USD 0.16 per share, based on the same Yahoo Finance overview. That comparison is the clearest operating signal in the available figures because it places the quarter's earnings above the cited estimate.

Analyst target rises to USD 64

Needham maintained its Buy rating and raised its price target from USD 45 to USD 64 on September 2, 2026, according to Yahoo Finance. The increase of USD 19 represents a 42.22 percent rise in the target, while the cited analyst average target was USD 53.33.

The target range shown in the same September 22, 2026 overview extended from USD 36.00 to USD 65.00. With the stock at USD 57.26, the average target of USD 53.33 was USD 3.93 below the quoted price, whereas Needham's USD 64 target was USD 6.74 above it.

Stock remains near yearly high

Yahoo Finance listed AtriCure's market capitalization at USD 2.913 billion and trading volume at 294,348 shares on September 22, 2026. The 52-week range of USD 25.36 to USD 59.88 places the quoted price at 94.37 percent of the distance from the low to the high.

The next earnings date shown by Yahoo Finance is October 27, 2026. For investors, the upcoming report is the next concrete checkpoint for testing whether the USD 153.6 million second-quarter revenue base and the USD 8.96 million earnings figure continue into the following quarter.

AtriCure stock stays below its high

AtriCure stock was quoted at USD 57.26 on Nasdaq on September 22, 2026, with a daily change of minus 1.45 percent and a prior close of USD 58.10. The market capitalization was USD 2.913 billion as of the same date.